Abstract
Unlike current gene therapy scenarios which focus on single gene replacement or overexpression to substitute for somatic genetic deficiencies, 3rd generation gene therapy strategies will require more complex multiregulated multigene interventions to reprogram or substitute entire regulatory networks and metabolic pathways to cure complex multifactorial human disease. Dual-regulated expression technology enables independent control of two different set(s) of transgenes and represents a first step towards multiregulated molecular interventions in mammalian and human cells. We have designed the dual-regulated expression vector pDuoRex? which contains divergently oriented streptogramin- (PPIR) and tetracycline- (PhCMV*-1) responsive promoters. A stuff er fragment of about 600 bp placed between PPIR and PhCMV*-1 prevents any interference between both expression units previously observed with other divergent promoter configurations. pDuoRex7 was engineered to express two marker genes encoding the yellow and cyan fluorescent proteins (pDuoRex8) in response to clinically licensed streptogramin- (PI) and tetracycline (Tet) andbiotics. pDuoRex8 enabled completely independent control of both fluorescent proteins in a variety of mammalian and human cell lines (CHO-K1, NIH/3T3 and K-562 cells) stably expressing a retroviral pTWIN vector (pRetroTwin3) driving constitutive expression of the streptogramin- (PIT) and tetracycline- (tTA) dependent transactivators. The combination of the pRetroTWIN vector series and pDuoRex vector families results in a dual-regulated expression concept with powerful impact on rationale reprogramming of mammalian cells. Here we present the latest generation of the dual-regulated expression technology.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Fussenegger, M., and Bailey, J.E. (1998) Molecular regulation of cell-cycle progression and apoptosis in mammalian cells: Implication for Biotechnology. Biotechnol. Prog. 14, 807–833.
Fussenegger, M. (2001) The impact of mammalian gene regulation concepts on functional genomic research, metabolic engineering, and advanced gene therapies. Biotechnol. Prog. 17, 1–51.
Fussenegger M., Bailey, I.E., and Varner J. (2000) A mathematical model of caspase funcdon in apoptosis. Nat. Biotechnol. 18, 768–774.
Moradpour, D., Englert, C., and Blum, H.E. (1998) Independent reguladon of two separate gene activities in acondnuous human cell line. Biol. Chem. 379, 1189–1191.
Fussenegger, M., Morris, R.P,, Eux, C., Rimann, M., von Stockar, B., Thompson, C.J. and Bailey, J.E. (2000) Streptogramin-based gene reguladon systems for mammalian cells. Nat. Biotechnol. 18, 1203–1208.
Moser, S., Schlatter, S., Eux, C., Rimann, M., Bailey, J.E., and Fussenegger, M. (2000) An update of pTRIDENT multicistronic expression vectors: pTRIDENTs containing novel streptogramin-responsive promoters. Biotechnol. Prog. 16, 724–735.
Anbei, D., Morris, R.P., Lennon, B., Rimann, M., Kaufmann, H., Folcher, M., Bailey, J.E., Thompson, C.J., and Fussenegger, M. (2001) Design of a novel mammalian screening system for the detection of bioavailable, non-cytotoxic streptogramin antibiotics. J. of Antibiotics 54, 44–55.
Moser, S., Rimann, M., Eux, C., Schlatter, S., Bailey, J.E., and Fussenegger, M. (2001) Dual-Regulated expression technology, a new era in adjusdng heterologous gene expression in mammalian cells. J. Gen. Med., in press.
Fussenegger, M. (2001) Dual-regulated gene expression in mammalian cells, a novel approach to gene therapy. Gene Therapy and Regulation, in press.
Fux, C., Moser, S., Schlatter, S., Rimann, M., Bailey, J.E., and Fussenegger, M. (2001) Streptogramin-and tetracycline-responsive dual-regulated expression of p27Kip1 sense and antisense enables positive and negative growth control of Chinese hamster ovary cells. Nucleic Acids Res. 29, el9.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Fux, C., Fussenegger, M. (2001). Improved Dual-Regulated Expression Systems for Independent Control of Two Different Transgenes. In: Lindner-Olsson, E., Chatzissavidou, N., Lüllau, E. (eds) Animal Cell Technology: From Target to Market. ESACT Proceedings, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0369-8_28
Download citation
DOI: https://doi.org/10.1007/978-94-010-0369-8_28
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-3897-3
Online ISBN: 978-94-010-0369-8
eBook Packages: Springer Book Archive